More than two thirds of patients with relapsing-remitting multiple sclerosis, who were treated with a combination of high-dose chemotherapy and stem cell transplantation, have been in remission for 5 years, according to the results of a small clinical trial. Researchers suggest that a combination of high-dose chemotherapy and stem cell transplantation could lead to long-term...